Darwin Global Management, Ltd.

Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2021		-2.2%	$0	0	-253,692	-100%	$67.61	Q4 2021
30 Sep 2021	2.2%	-0.72%	$11,891,000	253,692	-83,125	-25%	$46.87	Q3 2021
30 Jun 2021	3.3%	-17%	$20,532,000	336,817	-1,753,332	-84%	$60.96	Q2 2021
31 Mar 2021	25%	+17%	$128,753,000	2,090,149	+1,427,191	+215%	$61.60	Q1 2021
31 Dec 2020	13%	0%	$47,143,000	662,958	0		$71.11	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.